文献速递流行病学与生物统计临床试验与 GCP

清醒俯卧位在covid-19相关低氧性呼吸衰竭患者中的疗效:随机试验的系统综述与Meta分析

Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis of randomized trials.
PubMed 文献 · BMJ · 2022-12-07

该系统综述与Meta分析纳入17项随机试验共2931例covid-19相关低氧性呼吸衰竭的未插管成人患者,比较清醒俯卧位与常规治疗。清醒俯卧位降低气管插管风险(粗率24.2% vs 29.8%,RR 0.83,95%CI 0.73至0.94;高确定性),但未显著影响死亡率等次要结局。

要点

  • 清醒俯卧位较常规治疗降低气管插管风险(RR 0.83,95%CI 0.73至0.94;高确定性)。
  • 每1000例患者减少55例插管(95%CI 减少87至19例)。
  • 死亡率、无呼吸机天数、ICU及住院时长、氧疗升级等次要结局无显著差异。

核心结论

  • 与常规治疗相比,清醒俯卧位可降低covid-19相关低氧性呼吸衰竭成人的气管插管风险,但对死亡率或其他结局可能几乎无影响。

研究设计与样本

  • 系统综述与频率学派及贝叶斯Meta分析;检索Medline、Embase和Cochrane对照试验中心注册库自建库至2022年3月4日;纳入比较清醒俯卧位与常规治疗的随机试验;共17项试验、2931例患者;12项偏倚风险低、3项存在一定担忧、2项偏倚风险高。

主要发现

  • 气管插管粗率清醒俯卧位组24.2% vs 常规治疗组29.8%(RR 0.83,95%CI 0.73至0.94;高确定性),相当于每1000例减少55例插管(95%CI 减少87至19例)。
  • 死亡率清醒俯卧位组15.6% vs 常规治疗组17.2%(RR 0.90,95%CI 0.76至1.07;高确定性),无显著差异。
  • 无呼吸机天数平均差0.97天(95%CI -0.5至3.4;低确定性);ICU住院时长平均差-2.1天(95%CI -4.5至0.4;低确定性);住院时长平均差-0.09天(95%CI -0.69至0.51;中等确定性)。
  • 氧疗升级清醒俯卧位组21.4% vs 常规治疗组23.0%(RR 1.04,95%CI 0.74至1.44;低确定性);与清醒俯卧位相关的不良事件不常见。
  • 贝叶斯Meta分析(无信息先验)气管插管平均RR 0.83(95%可信区间0.70至0.97;RR<0.95的后验概率96%);死亡率平均RR 0.90(95%可信区间0.73至1.13;RR<0.95的后验概率68%)。

临床怎么用

  • 原文结论为清醒俯卧位较常规治疗降低covid-19相关低氧性呼吸衰竭成人的气管插管风险,但对死亡率或其他结局可能几乎无影响。

局限性

  • 2项试验为高偏倚风险、3项存在一定担忧。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the efficacy and safety of awake prone positioning versus usual care in non-intubated adults with hypoxemic respiratory failure due to covid-19. DESIGN: Systematic review with frequentist and bayesian meta-analyses. STUDY ELIGIBILITY: Randomized trials comparing awake prone positioning versus usual care in adults with covid-19 related hypoxemic respiratory failure. Information sources were Medline, Embase, and the Cochrane Central Register of Controlled Trials from inception to 4 March 2022. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data and assessed risk of bias. Random effects meta-analyses were performed for the primary and secondary outcomes. Bayesian meta-analyses were performed for endotracheal intubation and mortality outcomes. GRADE certainty of evidence was assessed for outcomes. MAIN OUTCOME MEASURES: The primary outcome was endotracheal intubation. Secondary outcomes were mortality, ventilator-free days, intensive care unit (ICU) and hospital length of stay, escalation of oxygen modality, change in oxygenation and respiratory rate, and adverse events. RESULTS: 17 trials (2931 patients) met the eligibility criteria. 12 trials were at low risk of bias, three had some concerns, and two were at high risk. Awake prone positioning reduced the risk of endotracheal intubation compared with usual care (crude average 24.2% v 29.8%, relative risk 0.83, 95% confidence interval 0.73 to 0.94; high certainty). This translates to 55 fewer intubations per 1000 patients (95% confidence interval 87 to 19 fewer intubations). Awake prone positioning did not significantly affect secondary outcomes, including mortality (15.6% v 17.2%, relative risk 0.90, 0.76 to 1.07; high certainty), ventilator-free days (mean difference 0.97 days, 95% confidence interval -0.5 to 3.4; low certainty), ICU length of stay (-2.1 days, -4.5 to 0.4; low certainty), hospital length of stay (-0.09 days, -0.69 to 0.51; moderate certainty), and escalation of oxygen modality (21.4% v 23.0%, relative risk 1.04, 0.74 to 1.44; low certainty). Adverse events related to awake prone positioning were uncommon. Bayesian meta-analysis showed a high probability of benefit with awake prone positioning for endotracheal intubation (non-informative prior, mean relative risk 0.83, 95% credible interval 0.70 to 0.97; posterior probability for relative risk <0.95=96%) but lower probability for mortality (0.90, 0.73 to 1.13; <0.95=68%). CONCLUSIONS: Awake prone positioning compared with usual care reduces the risk of endotracheal intubation in adults with hypoxemic respiratory failure due to covid-19 but probably has little to no effect on mortality or other outcomes. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022314856.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Weatherald J, Parhar KKS, Al Duhailib Z, et al. Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis of randomized trials. BMJ. 2022. PMID: 36740866. doi:10.1136/bmj-2022-071966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。